Natural killer cells eradicate galectin-1-deficient glioma in the absence of adaptive immunity.
about
Overview of current immunotherapeutic strategies for gliomaTGF-β signaling and its targeting for glioma treatmentHeterologous expression of newly identified galectin-8 from sea urchin embryos produces recombinant protein with lactose binding specificity and anti-adhesive activity.Concise Review: Targeting Cancer Stem Cells Using Immunologic ApproachesIsolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear CellsThe multidrug-resistance transporter Abcc3 protects NK cells from chemotherapy in a murine model of malignant glioma.Natural killer cells require monocytic Gr-1(+)/CD11b(+) myeloid cells to eradicate orthotopically engrafted glioma cellsCXCR4 increases in-vivo glioma perivascular invasion, and reduces radiation induced apoptosis: A genetic knockdown study.Re-wiring regulatory cell networks in immunity by galectin-glycan interactions.The Long and Winding Road: From the High-Affinity Choline Uptake Site to Clinical Trials for Malignant Brain Tumors.Cracking the glioma-NK inhibitory code: toward successful innate immunotherapy.Evolutionary basis of a new gene- and immune-therapeutic approach for the treatment of malignant brain tumors: from mice to clinical trials for glioma patients.Galectin-1 is a poor prognostic factor in patients with glioblastoma multiforme after radiotherapy.Current state and future prospects of immunotherapy for glioma.Immune heterogeneity and clinicopathologic characterization of IGFBP2 in 2447 glioma samples.Molecular Ablation of Tumor Blood Vessels Inhibits Therapeutic Effects of Radiation and Bevacizumab.Blockade of Na/H exchanger stimulates glioma tumor immunogenicity and enhances combinatorial TMZ and anti-PD-1 therapy
P2860
Q26776345-8FBF808C-B8B2-4D22-90A9-E00BB6A024DAQ28082042-0E155D58-F2DB-4D25-9C32-F930F93184A1Q30382203-15AFBB33-A6F8-4013-BB03-2E9B343DBA7AQ35772708-0547633E-D4FC-4902-AFC7-C3EC66576A5DQ36408364-DC75AC85-5022-4646-A9DD-D25A3F45FF01Q37012579-BC1BAC86-0900-45C5-BB7A-CD63BCA087EEQ37079098-F04E98A3-B0D6-44C9-94D6-7DD250C56ED8Q37686164-9E571E2F-8E86-4150-A740-C821C461AE05Q38583449-024A08E9-579A-49A1-B16A-C79FCBF0253AQ41189810-7C0B1397-26E4-4252-9221-B31C01325C67Q43103834-E463F4CB-C4C4-4C47-BCFE-AFD599A9D4FCQ47318878-AF74C958-2EC3-4893-AE75-DDE506E6C7A0Q47706727-43B614D0-B97E-4FC5-9C75-8662831487FAQ50109459-CFBA063C-9344-4431-A0A4-1C7660C15A37Q55457206-D998EE52-B264-4F2E-8D74-E3C1A862C029Q55457297-89A08D2E-6AB3-47CF-90E4-D88DB037325CQ59129078-B54ACCC9-322D-4E35-93CB-773B8E55EE55
P2860
Natural killer cells eradicate galectin-1-deficient glioma in the absence of adaptive immunity.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Natural killer cells eradicate ...... absence of adaptive immunity.
@ast
Natural killer cells eradicate ...... absence of adaptive immunity.
@en
Natural killer cells eradicate ...... absence of adaptive immunity.
@nl
type
label
Natural killer cells eradicate ...... absence of adaptive immunity.
@ast
Natural killer cells eradicate ...... absence of adaptive immunity.
@en
Natural killer cells eradicate ...... absence of adaptive immunity.
@nl
prefLabel
Natural killer cells eradicate ...... absence of adaptive immunity.
@ast
Natural killer cells eradicate ...... absence of adaptive immunity.
@en
Natural killer cells eradicate ...... absence of adaptive immunity.
@nl
P2093
P2860
P50
P1433
P1476
Natural killer cells eradicate ...... absence of adaptive immunity.
@en
P2093
Michael Ritt
Pedro R Lowenstein
Sivaraj Sivaramakrishnan
Viveka Nand Yadav
P2860
P304
P356
10.1158/0008-5472.CAN-14-1203
P407
P577
2014-07-18T00:00:00Z